Table 5 Results of multiple linear regression analyses of cytokine levels in patients with cancer 3 and 6 months after diagnosis compared with those at diagnosis represented as geometric mean ratios with 95% confidence intervals (coefficients of the models) and the corresponding P values.
Cytokine | Children | Adolescents | ||
---|---|---|---|---|
3 months versus at diagnosis | 6 months versus at diagnosis | 3 months versus at diagnosis | 6 months versus at diagnosis | |
IFN-γ | 1.11 (0.48, 2.57), P = 0.80 | 0.78 (0.33, 1.83), P = 0.56 | 1.02 (0.45, 2.35), P = 0.95 | 0.65 (0.27, 1.55), P = 0.32 |
IL-1a | 0.61 (0.29, 1.28), P = 0.18 | 0.46 (0.22, 0.99), P = 0.046 | 0.65 (0.31, 1.35), P = 0.24 | 0.53 (0.24, 1.14), P = 0.099 |
IL-1β | 1.21 (0.42, 3.46), P = 0.71 | 0.49 (0.17, 1.44), P = 0.19 | 0.69 (0.25, 1.95), P = 0.47 | 0.32 (0.11, 0.96), P = 0.043 |
IL-4 | 1.09 (0.66, 1.80), P = 0.73 | 0.98 (0.59, 1.63), P = 0.94 | 1.22 (0.75, 2.00), P = 0.41 | 0.86 (0.51, 1.44), P = 0.55 |
IL-5 | 1.25 (0.67, 2.30), P = 0.47 | 1.05 (0.56, 1.96), P = 0.88 | 1.35 (0.74, 2.47), P = 0.32 | 1.08 (0.57, 2.05), P = 0.81 |
IL-6 | 4.25 (1.32, 13.8), P = 0.018 | 0.83 (0.25, 2.72), P = 0.75 | 1.63 (0.51, 5.18), P = 0.40 | 0.50 (0.15, 1.68), P = 0.25 |
IL-8 | 0.93 (0.48, 1.82), P = 0.83 | 0.53 (0.27, 1.06), P = 0.070 | 0.69 (0.36, 1.34), P = 0.26 | 0.40 (0.20, 0.79), P = 0.011 |
IL-10 | 1.75 (0.87, 3.54), P = 0.11 | 0.90 (0.44, 1.84), P = 0.76 | 2.65 (1.33, 5.29), P = 0.008 | 0.86 (0.41, 1.79), P = 0.67 |
IP-10 | 4.24 (1.19, 15.1), P = 0.027 | 1.88 (0.51, 6.88), P = 0.33 | 2.55 (0.73, 8.93), P = 0.14 | 1.99 (0.53, 7.53), P = 0.30 |
TNF | 1.33 (0.68, 2.61), P = 0.39 | 0.69 (0.35, 1.37), P = 0.28 | 1.23 (0.63, 2.38), P = 0.53 | 0.61 (0.31, 1.23), P = 0.16 |
VEGF-A | 0.87 (0.41, 1.83), P = 0.70 | 0.58 (0.27, 1.23), P = 0.15 | 0.86 (0.41, 1.78), P = 0.67 | 0.53 (0.25, 1.15), P = 0.10 |
IL-13 | 1.33 (0.64, 2.78), P = 0.43 | 1.06 (0.50, 2.24), P = 0.87 | 1.69 (0.82, 3.49), P = 0.15 | 1.03 (0.48, 2.22), P = 0.93 |